Metagenomi Therapeutics paid its 4 named executives $4.8M in total in FY2025 (Dec). CEO Jian Irish, Ph.D., M.B.A. was paid $1.7M of that.
Pay$100 in the stock at the end of FY24 → $45
Pay of each named executive
Jian Irish, Ph.D., M.B.A.President and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Brian C. Thomas, Ph.D.Former Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Pamela Wapnick, M.B.A.Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Matthew L. Wein, J.D.General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.